{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:30:45Z","timestamp":1793755845253,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejim.2026.106839","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:20:18Z","timestamp":1773836418000},"page":"106839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["It\u2019s time to improve antithrombotic therapy! A global perspective for antithrombotic stewardship"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-8879","authenticated-orcid":false,"given":"W","family":"Ageno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"L","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lindhoff-Last","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GYH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-0465","authenticated-orcid":false,"given":"K","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-0767","authenticated-orcid":false,"given":"M","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Bessada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Triller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-4975","authenticated-orcid":false,"given":"A","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106839_bib0001","first-page":"180","article-title":"Comments on \u201csafe and effective anticoagulation use: case studies in anticoagulation stewardship","volume":"2","author":"Marietta","year":"2025","journal-title":"Bleeding Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2026.106839_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2022.100125","article-title":"Advancing anticoagulation stewardship: a call to action for stewardship from the US-based Anticoagulation Forum","volume":"9","author":"Burnett","year":"2022","journal-title":"Thromb Update"},{"key":"10.1016\/j.ejim.2026.106839_bib0003","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s11606-020-05904-0","article-title":"Oral anticoagulant utilization in the United States and United Kingdom","volume":"35","author":"Colacci","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ejim.2026.106839_bib0004","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Euro Heart J"},{"key":"10.1016\/j.ejim.2026.106839_bib0005","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/europace\/euz141","article-title":"Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project","volume":"21","author":"Di Carlo","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2026.106839_bib0006","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/a-1528-0513","article-title":"Increasing use of anticoagulants in Germany and its impaact on hospitalization for tooth extraction","volume":"42","author":"von Beckerath","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.ejim.2026.106839_bib0007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.21917","article-title":"Prevalence of clinical venous thromboembolism in the USA: current trends and future projections","volume":"86","author":"Deitelzweig","year":"2010","journal-title":"Amer J Hemat"},{"key":"10.1016\/j.ejim.2026.106839_bib0008","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.3390\/jcm9092984","article-title":"A review of the incidence, diagnosis, and treatment of spontaneous hemorrhage in patients treated with direct oral anticoagulants","volume":"9","author":"Gunasekaran","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2026.106839_bib0009","unstructured":"https:\/\/www.who.int\/initiatives\/patients-for-patient-safety. (accessed 03\/14\/2026)."},{"key":"10.1016\/j.ejim.2026.106839_bib0010","series-title":"Core elements of hospital antibiotic stewardship programs","year":"2019"},{"key":"10.1016\/j.ejim.2026.106839_bib0011","unstructured":"Antimicrobial stewardship \u2013 understanding the requirements | critical access hospital | medication management MM | the joint commission [internet]. Available from: https:\/\/www.jointcommission.org\/standards\/standard-faqs\/critical-access-hospital\/medication-management-mm\/000002045\/ (accessed 03\/14\/2026)."},{"key":"10.1016\/j.ejim.2026.106839_bib0012","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2021.13844","article-title":"US emergency department visits attributed to medication harms 2017-2019","volume":"326","author":"Budnitz","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2026.106839_bib0013","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"The pharmacology and management of the vitamin K antagonists: ACCP evidence-based clinical practice guidelines","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2026.106839_bib0014","unstructured":"Core principles of anticoagulation stewardship - https:\/\/acforum.org\/web\/stewardship-core-elements.php (accessed 03\/14\/2026)."},{"key":"10.1016\/j.ejim.2026.106839_bib0015","unstructured":"Advancing anticoagulation stewardship: a playbook. https:\/\/acforum-excellence.org\/Resource-Center\/resource_files\/1977-2022-08-24-063128.pdf (accessed 03\/14\/2026)."},{"key":"10.1016\/j.ejim.2026.106839_bib0016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-006-9022-7","article-title":"Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM)","volume":"23","author":"Ansell","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2026.106839_bib0017","first-page":"833","article-title":"Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry","volume":"111","author":"Le Heuzey","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106839_bib0018","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1345\/aph.1R634","article-title":"Delivery of optimized inpatient anticoagulation therapy: consensus statement from the Anticoagulation Forum","volume":"47","author":"Nutescu","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2026.106839_bib0019","first-page":"1890","article-title":"Frequency of and risk factor for preventable medication related hospital admissions in the Netherlands","volume":"168","author":"Leendertse","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2026.106839_bib0020","doi-asserted-by":"crossref","unstructured":"Frappe P., Cogneau J., Gaboreau Y., et al. Areas of improvement in anticoagulant safety. Data from the CACAO study, a cohort in general practice. PLoS ONE 2017;12(4):e0175167.","DOI":"10.1371\/journal.pone.0175167"},{"key":"10.1016\/j.ejim.2026.106839_bib0021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2023.03.010","article-title":"Bleeding related to oral anticoagulants: trends in US emergency department visits 2016-2020","volume":"225","author":"Geller","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2026.106839_bib0022","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/bloodadvances.2021006534","volume":"7","author":"Neumann","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.ejim.2026.106839_bib0023","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11239-023-02928-1","article-title":"Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa","volume":"57","author":"Mwita","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2026.106839_bib0024","article-title":"Real world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation. a systematic review and meta-analysis","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ: Cardiovas Qual Outcomes"},{"key":"10.1016\/j.ejim.2026.106839_bib0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40119-023-00315-8","article-title":"Anticoagulant treatment adherence and persistence in German patients with atrial fibrillation","volume":"12","author":"Patti","year":"2023","journal-title":"Cardio Ther"},{"key":"10.1016\/j.ejim.2026.106839_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.682890","article-title":"Adherence to direct oral anticoagulants in patients with non-valvular atrial fibrillation: a cross-national comparison in six European countries (2008-2015)","volume":"12","author":"Sabate","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2026.106839_bib0027","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/europace\/euab091","article-title":"Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five western European countries","volume":"23","author":"Komen","year":"2021","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ejim.2026.106839_bib0028","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/jcm13072009","article-title":"Inappropriate underdosing of direct oral anticoagulants in atrial fibrillation patients: results from the START2-AF Registry","volume":"13","author":"Poli","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2026.106839_bib0029","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/europace\/eux316","article-title":"Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A sub analysis of the FANTASIA Registry","volume":"20","author":"Ortiz","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2026.106839_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11239-018-1690-6","article-title":"Non-recommended dosing of direct oral anticoagulants in acute pulmonary embolism is related to an increased rate of adverse events","volume":"46","author":"Chopard","year":"2018","journal-title":"J Thromb Thromboly"},{"key":"10.1016\/j.ejim.2026.106839_bib0031","article-title":"Clinical impact of inappropriate DOAC dosing in atrial fibrillation: insights from a real-world registry","volume":"56","author":"Yildirim","year":"2025","journal-title":"IJC Heart Vasc"},{"key":"10.1016\/j.ejim.2026.106839_bib0032","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2023.03.007","article-title":"Inappropriate prescriptions of direct oral anticoagulants (DOACS) in hospitalized patients: a narrative review","volume":"231","author":"Van der Horst","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2026.106839_bib0033","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00228-021-03212-y","article-title":"Prevalence, contributory factors and severity of medication errors associated with direct acting oral anticoagulants in adult patients: a systematic review and meta-analysis","volume":"78","author":"Al Rowily","year":"2022","journal-title":"Euro J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2026.106839_bib0034","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/14740338.2023.2223947","article-title":"Contributory factors and patient harm including deaths associated direct acting oral anticoagulants (DOACs) medication incidents: evaluation of real-world data reported to the National Reporting and Learning System","volume":"22","author":"Al Rowily","year":"2023","journal-title":"Exp Opin Drug Saf"},{"key":"10.1016\/j.ejim.2026.106839_bib0035","article-title":"Off-label under-and overdosing of direct oral anticoagulants in patients with atrial fibrillation: a meta-analysis","volume":"14e","author":"Zhang","year":"2021","journal-title":"Circ: Cardiovas Qual Outcomes"},{"key":"10.1016\/j.ejim.2026.106839_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.581293","article-title":"Real-0world prevalence of direct oral anticoagulant off-label doses in atrial fibrillation: an epidemiological meta-0analysis","volume":"12","author":"Shen","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2026.106839_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2025.100210","article-title":"Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation","volume":"20","author":"Jansson","year":"2025","journal-title":"Thromb Update"},{"key":"10.1016\/j.ejim.2026.106839_bib0038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40266-023-01006-8","article-title":"Inappropriate combined antiplatelet and anticoagulant therapy in older patients with atrial fibrillation: trend over time (2009-2018)","volume":"40","author":"Philippe","year":"2023","journal-title":"Drug Aging"},{"key":"10.1016\/j.ejim.2026.106839_bib0039","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamainternmed.2021.1197","article-title":"Adverse events associated with addition of aspirin to direct oral anticoagulant therapy without a clear indication","volume":"181","author":"Schaefer","year":"2021","journal-title":"JAMA Int Med"},{"issue":"2","key":"10.1016\/j.ejim.2026.106839_bib0040","article-title":"Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis","volume":"6","author":"Ya","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ejim.2026.106839_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235048","article-title":"Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization","volume":"15","author":"Dreijer","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2026.106839_bib0042","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jamainternmed.2025.0640","article-title":"Emergency department visits for medication-related events with vs without pharmacist interventions. The URGEIM randomized clinical trial","volume":"185","author":"Villiet","year":"2025","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.ejim.2026.106839_bib0043","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13584-019-0285-9","article-title":"Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program","volume":"8","author":"Perlman","year":"2019","journal-title":"Isr J Health Pol Res"},{"key":"10.1016\/j.ejim.2026.106839_bib0044","first-page":"488","article-title":"The effect of pharmacist-led interventions on the appropriateness and clinical outcomes of anticoagulant therapy: a systematic review and meta-analysis","volume":"10","author":"Kefale","year":"2024","journal-title":"Euro Heart J-Qual Care Clin Outcomes"},{"key":"10.1016\/j.ejim.2026.106839_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43094-025-00791-w","article-title":"Clinical pharmacist-led anticoagulation stewardship program: improve physician adherence to evidence-based guidelines and reduce anticoagulant-related medication errors","volume":"11","author":"El-Bosily","year":"2025","journal-title":"Future J Pharm Sci"},{"key":"10.1016\/j.ejim.2026.106839_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2021.104575","article-title":"Development and implementation of venous thromboembolism stewardship across a hospital network","volume":"155","author":"Chong","year":"2021","journal-title":"Intern J Med Informat"},{"key":"10.1016\/j.ejim.2026.106839_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2022.11.016","article-title":"Impact of hospital-based multidisciplinary anticoagulation stewardship programs","volume":"54","author":"Porres-Aguilar","year":"2022","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ejim.2026.106839_bib0048","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/hemato4030018","article-title":"Efficacy of an anticoagulation clinic in low-income Brazilian patients with heart disease: a randomized clinical trial","volume":"4","author":"Martins","year":"2023","journal-title":"Hemato"},{"key":"10.1016\/j.ejim.2026.106839_bib0049","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106839_bib0050","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"Romiti","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106839_bib0051","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-025-03224-w","article-title":"Implementing anticoagulation stewardship: the use of a dedicated mobile phone app in the experience of the Italian Federation of Anticoagulant clinics","author":"Poli","year":"2025","journal-title":"J Thromb Thromboly"},{"key":"10.1016\/j.ejim.2026.106839_bib0052","article-title":"Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review","volume":"7","author":"Cogan","year":"2023","journal-title":"Res Pr Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106839_bib0053","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1055\/a-2259-0911","article-title":"Anticoagulation stewardship to bridge the implementation gap in perioperative anticoagulation management","volume":"8","author":"Tarfur","year":"2024","journal-title":"TH Open"},{"key":"10.1016\/j.ejim.2026.106839_bib0054","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1111\/bcp.14071","article-title":"Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): a cross-national drug utilization study","volume":"85","author":"Ibanez","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2026.106839_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2023.100158","article-title":"Value of hospital anticoagulation stewardship programme: a systematic review","author":"Silvari","year":"2024","journal-title":"Thromb Update"},{"key":"10.1016\/j.ejim.2026.106839_bib0056","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtha.2023.10.002","article-title":"Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day","volume":"22","author":"Malerba","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106839_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102761","article-title":"177 The current landscape of anticoagulation (AC) stewardship implementation around the world: an international survey","volume":"9","author":"Shapiro","year":"2025","journal-title":"Res Pract Thromb Haemost"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:11:54Z","timestamp":1780139514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526001445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":57,"alternative-id":["S0953620526001445"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106839","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"It\u2019s time to improve antithrombotic therapy! A global perspective for antithrombotic stewardship","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106839"}}